Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPS: PK-guided vs Standard Hydroxyurea in Pediatric SCA
NCT03789591Phase 3Completed
- Sponsor
- Lifespan Biotech
- Start
- Jan 2019
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by Lifespan Biotech. Started Jan 2019; status: completed.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT03789591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789591.